Digitalis is effective for pediatric heart failure and arrhythmias but requires careful management of dosing and electrolyte status to avoid severe toxicity.
Answers are grounded in this paper and cite their sources.
Requires extreme caution with digitalis in children; leaves open need for contemporary dosing trials.
Digitalis, properly administered, is the best single therapeutic agent for control of heart failure and many of the supraventricular arrhythmias in infants and children, but adjunctive measures are also necessary. Overdosage is associated with severe toxicity. The purified digitalis preparations have virtually replaced the crude forms of the drug, and their use requires extreme caution because of their potency; this is especially true in both newborn and premature infants. Choice of preparation is not as important as knowledge of therapeutic as well as toxic manifestations. The patient's electrolyte status significantly influences the effect of digitalis.
No takes yet. Share an insight, caveat, or question.
Saul J. Robinson (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: